ZA973071B - Novel peptides suitable for use in antigen specific immuno-suppressive therapy - Google Patents

Novel peptides suitable for use in antigen specific immuno-suppressive therapy

Info

Publication number
ZA973071B
ZA973071B ZA973071A ZA973071A ZA973071B ZA 973071 B ZA973071 B ZA 973071B ZA 973071 A ZA973071 A ZA 973071A ZA 973071 A ZA973071 A ZA 973071A ZA 973071 B ZA973071 B ZA 973071B
Authority
ZA
South Africa
Prior art keywords
antigen specific
novel peptides
peptides suitable
suppressive therapy
specific immuno
Prior art date
Application number
ZA973071A
Other languages
English (en)
Inventor
Anna Maria Helena Boots
Gijsbertus Francisc Verheijden
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of ZA973071B publication Critical patent/ZA973071B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Transplantation (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA973071A 1996-04-24 1997-04-10 Novel peptides suitable for use in antigen specific immuno-suppressive therapy ZA973071B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96201106 1996-04-24

Publications (1)

Publication Number Publication Date
ZA973071B true ZA973071B (en) 1998-08-05

Family

ID=8223915

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA973071A ZA973071B (en) 1996-04-24 1997-04-10 Novel peptides suitable for use in antigen specific immuno-suppressive therapy

Country Status (20)

Country Link
US (1) US6184204B1 (xx)
EP (1) EP0920451A1 (xx)
JP (1) JP2000510106A (xx)
KR (1) KR20000010561A (xx)
CN (1) CN1216551A (xx)
AR (1) AR006813A1 (xx)
AU (1) AU719481B2 (xx)
BR (1) BR9708744A (xx)
CA (1) CA2251680A1 (xx)
CZ (1) CZ340698A3 (xx)
HU (1) HUP9901375A3 (xx)
IL (1) IL120561A0 (xx)
NO (1) NO984937L (xx)
NZ (1) NZ332427A (xx)
PL (1) PL329618A1 (xx)
RU (1) RU2199548C2 (xx)
TR (1) TR199802135T2 (xx)
TW (1) TW575583B (xx)
WO (1) WO1997040068A1 (xx)
ZA (1) ZA973071B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0103384A3 (en) 1998-07-23 2004-06-28 Akzo Nobel Nv Novel peptides for use in immunotherapy of autoimmune diseases
AU780238B2 (en) * 1999-10-18 2005-03-10 Akzo Nobel N.V. Modified peptides and peptidomimetics for use in immunotherapy
IL132611A0 (en) 1999-10-27 2001-03-19 Yeda Res & Dev Synthetic genes and polypeptides and pharmaceutical compositions comprising them
MXPA03001421A (es) 2000-08-14 2004-01-26 Johnson & Johnson Pirazoles sustituidos.
US7002985B2 (en) * 2001-01-16 2006-02-21 Motorola, Inc. Method and apparatus for organizing and scheduling multimedia data transfers over a wireless channel
EP1835027B1 (en) * 2004-12-07 2015-02-25 Toray Industries, Inc. Novel cancer antigen peptide and the use thereof
AU2006218237B2 (en) * 2005-02-28 2012-01-12 Bio-Y A/S YKL-40 monoclonal antibodies
FR2908654B1 (fr) * 2006-11-20 2014-04-04 Oreal Utilisation cosmetique de proteines de type chitinase
SI2172211T1 (sl) * 2008-10-01 2015-03-31 Immatics Biotechnologies Gmbh Sestavek s tumorjem povezanih peptidov in zadevnih cepiv proti raku za zdravljenje glioblastoma (GBM) in drugih vrst raka
RU2008140688A (ru) * 2008-10-15 2010-04-20 Михаил Аркадьевич Шурдов (RU) Иммуносупрессивный пептид
WO2010142041A1 (en) 2009-06-11 2010-12-16 The University Of Guelph Serine rich peptides having antioxidative stress properties
WO2011050471A1 (en) 2009-10-28 2011-05-05 University Of Manitoba Yellow pea seed protein-derived peptides
AU2011261107B2 (en) 2010-05-31 2016-04-14 London Health Sciences Centre Research Inc. RHAMM binding peptides
WO2018129261A1 (en) 2017-01-05 2018-07-12 Brown University Methods and compositions relating to anti-chi3l1 antibody reagents
US10766968B2 (en) 2017-08-23 2020-09-08 Brown University Methods and compositions relating to anti-CHI3L1 antibody reagents to treat cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2164498C (en) * 1993-07-09 2007-09-11 Paul A. Price Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices
IL115744A (en) * 1994-10-27 2000-07-16 Akzo Nobel Nv Peptides comprising a subsequence of human cartilage glycoprotein - 39

Also Published As

Publication number Publication date
NO984937D0 (no) 1998-10-23
CZ340698A3 (cs) 1999-02-17
CA2251680A1 (en) 1997-10-30
IL120561A0 (en) 1997-07-13
RU2199548C2 (ru) 2003-02-27
WO1997040068A1 (en) 1997-10-30
JP2000510106A (ja) 2000-08-08
AU2768597A (en) 1997-11-12
HUP9901375A2 (hu) 1999-08-30
NZ332427A (en) 2000-03-27
TW575583B (en) 2004-02-11
US6184204B1 (en) 2001-02-06
HUP9901375A3 (en) 2000-10-30
KR20000010561A (ko) 2000-02-15
AU719481B2 (en) 2000-05-11
AR006813A1 (es) 1999-09-29
PL329618A1 (en) 1999-03-29
TR199802135T2 (xx) 1999-01-18
BR9708744A (pt) 1999-08-03
CN1216551A (zh) 1999-05-12
NO984937L (no) 1998-12-01
EP0920451A1 (en) 1999-06-09

Similar Documents

Publication Publication Date Title
HK1096974A1 (en) Antibody against human parathormone related peptides
PL322589A1 (en) Radiotracer-labelled peptides for use in diagnostics and therapy
GB9601724D0 (en) Therapeutic agents
ZA973071B (en) Novel peptides suitable for use in antigen specific immuno-suppressive therapy
GB9600235D0 (en) Therapeutic agents
GB2321191B (en) Peptides for use in wound treatment
GB9419021D0 (en) Therapeutic protein
GB9516293D0 (en) Novel peptides and their use as vaccines
GB9626446D0 (en) Therapeutic device
EP1015033A4 (en) SUBSTITUTED PERYLENEQUINONES FOR USE IN PHOTODYNAMIC THERAPY
ZA96240B (en) Novel peptides their preparation and use
GB9605065D0 (en) Therapeutic agents
GB9620777D0 (en) Therapeutic use
ZA96239B (en) Novel peptides their preparation and use
GB9604400D0 (en) Compounds useful in therapy
GB9603136D0 (en) Therapeutic agents
GB9512896D0 (en) Peptides for use in vaccines
GB9613705D0 (en) Novel peptides
GB9615658D0 (en) Therapeutic agents
GB9312874D0 (en) Peptides for use in medicine
TW310631U (en) Improved medicine grinder
ZA959331B (en) Therapeutic protein
GB9601786D0 (en) Therapeutic agents
GB9508618D0 (en) Therapeutic protein
GB9620880D0 (en) Therapeutic use